Mobile stroke units are cutting critical treatment delays in acute ischaemic stroke, bringing substantially more patients to thrombolysis within the first hour after symptom onset. Evidence assessed in the International Journal of Emergency Medicine shows median treatment-time reductions of 20–41 minutes compared with standard emergency medical services. Across 13 studies involving 39,800 patients, golden-hour thrombolysis rose from less than 5% with conventional emergency care to 21–33% with mobile stroke units. The advantage was clearest in urban systems, although service design, staffing and dispatch processes also shaped performance and important questions remain about rural implementation, costs and longer-term outcomes.
Taking Stroke Treatment to the Patient
The main advantage of mobile stroke units comes from shifting key parts of stroke care out of the hospital and into the prehospital setting. Equipped with computed tomography scanners, point-of-care laboratory capabilities and access to specialist assessment, these units can diagnose eligible patients and begin thrombolysis at the scene rather than after transport and hospital imaging. That change consistently shortened the interval between symptom onset and treatment across the evidence examined.
The largest reductions reached 41 minutes, while even services operating against relatively efficient emergency systems still produced meaningful time savings. Across different settings and study designs, the pattern remained broadly consistent: treatment started earlier when diagnostic and thrombolysis capability travelled directly to the patient.
That advantage translated into a marked increase in treatment during the golden hour. In one Berlin service, 31.0% of patients received thrombolysis within 60 minutes of symptom onset compared with 4.9% under standard emergency care. Other programmes produced similar gains, with golden-hour treatment generally reaching 21–33% with mobile stroke units.
Must Read: Wearable PET System Advances Mobile Brain Imaging
Earlier treatment also expanded the proportion of patients receiving thrombolysis. Across 9 studies, treatment rates were 10–20% higher with mobile stroke units than with standard emergency medical services. The central benefit therefore extended beyond shaving minutes from an existing pathway: mobile services enabled more patients to reach treatment while the therapeutic window remained open.
Service Design Determines How Much Time Is Saved
The scale of the benefit depended heavily on how and where mobile stroke units operated. Urban systems generally achieved the most consistent gains, with reported time reductions of 25–41 minutes. Shorter transport distances, dense infrastructure and rapid dispatch allowed these services to reach patients quickly and complete assessment before hospital arrival.
Rural performance was less predictable. Reported reductions ranged from 20 to 40 minutes and longer travel distances and infrastructure constraints complicated deployment. A rendezvous model used in Gainesville, where a mobile stroke unit met conventional emergency services partway, nevertheless achieved a 40-minute reduction. Such results indicate that alternative operating models can preserve substantial time savings outside densely populated areas, although rural evidence remains limited.
Staffing choices did not appear to require a neurologist to be physically present in every unit. Services with onboard neurologists achieved reductions of up to 41 minutes, while telemedicine-based models produced savings of 30–37 minutes. In one major US programme, telemedicine and onboard neurological assessment performed comparably, while a Chinese service using 5G telemedicine also reported substantial acceleration of treatment.
Dispatch efficiency was another important determinant. Stroke-specific triage algorithms reduced false-positive activations and shortened deployment compared with less optimised systems. Witnessed stroke onset was associated with shorter treatment times, while nighttime operations still maintained meaningful reductions. These differences show that the value of a mobile stroke unit depends not only on the vehicle and its equipment but also on how well it is integrated into the surrounding emergency pathway.
Faster Care Shows Promise but Evidence Gaps Remain
The clinical value of faster treatment extended beyond process measures in some studies. Shorter thrombolysis times were associated with better functional outcomes, including a higher proportion of patients reaching modified Rankin Scale scores of 0–1 at 90 days. Lower disability at discharge was also reported in one large observational dataset.
The relationship was not uniform, however. One registry found no significant functional difference beyond the timing advantage and only 5 studies reported 90-day modified Rankin Scale outcomes. The available evidence therefore supports a consistent effect on treatment speed more strongly than it supports definitive conclusions about long-term functional benefit.
Implementation questions are also unresolved. Most available evidence comes from urban or predominantly urban systems, leaving uncertainty about how reliably mobile stroke units can be transferred to rural areas. Population diversity is similarly limited, with no included trials addressing paediatric acute ischaemic stroke or diverse ethnic groups.
Cost-effectiveness remains another major gap. Existing analyses suggest that mobile stroke units may be viable in urban settings with high patient volumes, but those findings depend on infrastructure and utilisation assumptions that may not apply elsewhere. Differences in staffing, computed tomography equipment, emergency service performance and study design further complicate direct comparison between programmes. More standardised outcome reporting and real-world evaluation are needed to determine where the model delivers the greatest benefit.
Mobile stroke units are moving acute stroke treatment closer to the point of first medical contact and consistently shortening the time to thrombolysis. Their strongest advantage is the increase in patients treated within the golden hour, supported by higher overall thrombolysis rates and some evidence of improved functional outcomes. Urban systems currently provide the clearest evidence of effectiveness, while telemedicine and alternative deployment models may widen the range of settings in which the approach can work. Rural feasibility, cost-effectiveness and longer-term patient outcomes remain the main uncertainties before broader implementation can be assessed.
Source: International Journal of Emergency Medicine
Image Credit: iStock
References:
Aderinto N, Olatunji G & Kokori E (2025) Effectiveness of mobile stroke units in reducing time to thrombolysis in acute ischemic stroke: a scoping review. Int J Emerg Med; 18, 109.
